diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference

_{//health-fitness.news-articles.net/content/2011/ .. the-canaccord-genuity-healthcare-conference.html}
^{Published in Health and Fitness on Monday, December 5th 2011 at 6:40 GMT by Market Wire}  

diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference -- SOUTH SAN FRANCISCO, Calif., Dec. 5, 2011 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about DDXS

SOUTH SAN FRANCISCO, Calif., Dec. 5, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: [ DDXS ]), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference on Tuesday, December 6, 2010 at 11:00 am Pacific Time (2:00 pm Eastern Time) at the St. Regis Hotel in San Francisco, CA.

Brian E. Ward, Ph.D., Chief Executive Officer of diaDexus, will provide a corporate overview presentation. To access the live webcast and the subsequent archived recording of the presentation, please log onto diaDexus' website at [ www.diadexus.com/webcast ].

About diaDexus, Inc.

diaDexus, Inc., based in South San Francisco, California, is focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease. The company's PLAC ELISA Test for Lp-PLA2 is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. For more information, please visit the company's website at [ www.diaDexus.com ]

Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference

SOURCE diaDexus, Inc.